Treatment success rate for patients treated for MDR-TB in Sweden

Sweden: Treatment success rate for patients treated for MDR-TB was 87.0% in 2022. ▲ Rising

Latest (2022)
87.0%
Change on year
down 13.0%
World rank
27th
of 163 countries
All-time high
100.0%
in 2006
All-time low
67.0%
in 2003
Years of data
19
2002–2022

Treatment success rate for patients treated for MDR-TB in Sweden, 2002–2022

0204060801002002201220222002: 752003: 672006: 1002007: 802008: 912009: 852010: 942011: 752012: 832013: 752014: 942015: 962016: 1002017: 832018: 1002019: 902020: 832021: 1002022: 87

Source: World Health Organization, Global Health Observatory.

Analysis

Sweden recorded 87.0% for treatment success rate for patients treated for mdr-tb in 2022.

Compared with earlier readings it is down 13.0% on the previous year and up 4.8% over ten years.

Over the whole period, treatment success rate for patients treated for mdr-tb in Sweden peaked at 100.0% in 2006 and was at its lowest, 67.0%, in 2003.

That places Sweden 27th out of 163 countries with data for 2022, putting it in the top quarter.

The long-run direction has been consistently rising across the 19 years of available data.

Treatment success rate for patients treated for MDR-TB in Sweden, year by year

Annual values for Treatment success rate for patients treated for MDR-TB (%) in Sweden, 2002 to 2022.
Year Value Change
2002 75.0%
2003 67.0% -10.7%
2006 100.0% +49.3%
2007 80.0% -20.0%
2008 91.0% +13.8%
2009 85.0% -6.6%
2010 94.0% +10.6%
2011 75.0% -20.2%
2012 83.0% +10.7%
2013 75.0% -9.6%
2014 94.0% +25.3%
2015 96.0% +2.1%
2016 100.0% +4.2%
2017 83.0% -17.0%
2018 100.0% +20.5%
2019 90.0% -10.0%
2020 83.0% -7.8%
2021 100.0% +20.5%
2022 87.0% -13.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 83.0% 67.0% 100.0% 6
2010s 89.0% 75.0% 100.0% 10
2020s 90.0% 83.0% 100.0% 3

Countries ranked near Sweden

  1. 25 Uganda 89.0% compare
  2. 26 Estonia 88.0% compare
  3. 27 Canada 87.0% compare
  4. 27 United States of America 87.0% compare
  5. 27 Rwanda 87.0% compare

See the full ranking of 175 places →

More health data for Sweden

All data for Sweden →

Frequently asked questions

What is treatment success rate for patients treated for mdr-tb in Sweden?
Treatment success rate for patients treated for mdr-tb in Sweden was 87.0% in 2022, according to World Health Organization, Global Health Observatory.
What is the highest treatment success rate for patients treated for mdr-tb recorded in Sweden?
The highest recorded value was 100.0% in 2006.
What is the lowest treatment success rate for patients treated for mdr-tb recorded in Sweden?
The lowest recorded value was 67.0% in 2003.
How does Sweden rank for treatment success rate for patients treated for mdr-tb?
Sweden ranks 27th out of 163 countries with data for 2022.
Is treatment success rate for patients treated for mdr-tb rising or falling in Sweden?
Over the last ten years it is up 4.8%. The long-run trend across the full record is rising.
Where does this Sweden data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 19 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Treatment success rate for patients treated for MDR-TB in Sweden. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 07 September 2026, from https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/sweden/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/sweden/">Treatment success rate for patients treated for MDR-TB in Sweden</a> — Statizoid

About this data

Indicator
Treatment success rate for patients treated for MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
175 places, 2,495 data points, 1999–2022
Last refreshed